Publication:
Efficacy and Treatment Persistence of First-Line Natalizumab vs. Interferon Beta or Glatiramer Acetate in Relapsing MS

Research Projects

Organizational Units

Journal Issue

Abstract

Description

8th Congress of the Pan-Asian-Committee-for-Research-and-Treatment-of-Multiple-Sclerosis (PACTRIMS) -- NOV 19-21, 2015 -- Seoul, SOUTH KOREA

Keywords

Citation

WoS Q

Scopus Q

Source

Volume

22

Issue

3

Start Page

418

End Page

419

Endorsement

Review

Supplemented By

Referenced By